In this study, we further found that PDE4DIP had a higher frequency of mutations in some cancers, including endometrial cancer, bladder cancer, melanoma, NSCLC, hematological malignancies, and BRCA. This evidence concerns the gene PDE4DIP and non-small cell lung carcinoma.